| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020556A2 Zinc finger-reactive antimicrobial compounds |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020440A1 Caspases and apoptosis |
| 04/13/2000 | WO2000020418A1 Xanthobaccin antibiotics |
| 04/13/2000 | WO2000020413A1 Novel 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydroxyisoquinoline derivatives, preparation method and use as fungicides |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020365A1 A process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds |
| 04/13/2000 | WO2000019999A1 Fulvic acid and its use in the treatment of various conditions |
| 04/13/2000 | WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | WO2000019976A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 04/13/2000 | WO2000001408A3 Haemophilus parasuis vaccine and diagnostic |
| 04/13/2000 | WO2000000634A3 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/13/2000 | WO2000000509A3 Peptides for inhibiting hpv e7 proteins |
| 04/13/2000 | WO1999062451A9 Topical transdermal treatments |
| 04/13/2000 | WO1999055875A3 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
| 04/13/2000 | WO1999053897A3 Topical formulation comprising poloxamers and further microbicides, and an applicator |
| 04/13/2000 | WO1999051265A9 Nucleic acid encoding hyaluronan synthase and methods of use |
| 04/13/2000 | DE19845285A1 Treatment or prophylaxis of feline infectious peritonitis, using glyoxal or derivative, preferably in combination with immunostimulant |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345240A1 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 04/13/2000 | CA2345212A1 Zinc finger-reactive antimicrobial compounds |
| 04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2344616A1 Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (tnf-.alpha.) expression |
| 04/12/2000 | EP0992581A2 Immunodominant human T-cell epitopes of hepatitis C virus |
| 04/12/2000 | EP0992580A2 Immunodominant human T-cell epitopes of Hepatitis C virus |
| 04/12/2000 | EP0992509A2 Novel macrolide derivatives |
| 04/12/2000 | EP0992502A1 2-(3-Phenyl-2-propenyl)-1,2,3,4-tetrahydro-isochinolin derivatives, process for their preparation and their use as fungicides |
| 04/12/2000 | EP0992501A2 Pyridonecarboxylic acid derivatives as antibacterial agents |
| 04/12/2000 | EP0992243A1 Prophylactic/remedial agent |
| 04/12/2000 | EP0992241A1 Medicinal compositions against helicobacter pylori |
| 04/12/2000 | EP0991771A2 Lentivirus based vector and vector system |
| 04/12/2000 | EP0991767A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components |
| 04/12/2000 | EP0991762A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
| 04/12/2000 | EP0991761A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 04/12/2000 | EP0991755A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 04/12/2000 | EP0991653A1 Novel compounds |
| 04/12/2000 | EP0991646A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same |
| 04/12/2000 | EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 04/12/2000 | EP0991415A1 Orally administrable solid ribavirin dosage forms and process for making them |
| 04/12/2000 | EP0759917B1 Novel selective inhibitors of viral or bacterial neuraminidases |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/12/2000 | CN1250377A Hydrophilic binary systems for the administration of cyclosporine |
| 04/12/2000 | CN1250054A New tylosin hydroxyl derivative and its producing process |
| 04/12/2000 | CN1051223C Toothpaste containing anti-pylorus spirabacillus medicine and its producing process |
| 04/11/2000 | US6048977 Clavulanic acid and salts thereof |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048870 Mannosidase inhibitor; immunostimulant |
| 04/11/2000 | US6048852 Bactericides |
| 04/11/2000 | US6048842 Antidiabetic agent |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048700 Detecting the presence of a bordetella antigen in a sample; contacting an antibody specific antigen with said sample and detecting binding of an antibody to bordetta antigen, binding of the antbody is an indicator of presence of antigen |
| 04/11/2000 | US6048685 In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
| 04/11/2000 | US6048553 Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases |
| 04/11/2000 | US6048539 Immunology |
| 04/11/2000 | US6048538 Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents |
| 04/11/2000 | US6048537 Concentration, purification, fragmentation, deactivation |
| 04/11/2000 | US6048536 Vaccine compositions |
| 04/11/2000 | US6048535 Multivalent in ovo avian vaccine |
| 04/11/2000 | US6048530 Inducing cytotoxic t-cell response against viruses, bacteria, fungi, and parasites; immunology |
| 04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
| 04/11/2000 | CA2120725C Chemical compounds |
| 04/11/2000 | CA2016656C Enzyme inhibitors |
| 04/11/2000 | CA1340957C Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics |
| 04/06/2000 | WO2000019206A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 04/06/2000 | WO2000018952A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | WO2000018902A1 Method of screening for large offspring syndrome |
| 04/06/2000 | WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2000 | WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 04/06/2000 | WO2000018799A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | WO2000018797A1 Map |
| 04/06/2000 | WO2000018775A1 Antiviral purine derivatives |
| 04/06/2000 | WO2000018735A1 2-substituted heterocyclic sulfonamides |
| 04/06/2000 | WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 04/06/2000 | WO2000018433A2 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 04/06/2000 | WO2000018432A1 Carbohydrate vaccines for viral diseases |
| 04/06/2000 | WO2000018430A2 Live virus vaccines to protect primates from hiv-1 infection and disease |
| 04/06/2000 | WO2000018429A2 Vaccine based on attenuated $i(haemophilus somnus) |
| 04/06/2000 | WO2000018419A2 Methods for administration of antibiotics |
| 04/06/2000 | WO2000018417A2 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine |
| 04/06/2000 | WO2000018404A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018388A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018386A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018365A2 Fast dissolving orally consumable films |
| 04/06/2000 | WO2000018355A2 Use of purified invaplex from gram negative bacteria as a vaccine |
| 04/06/2000 | WO2000018354A2 Invaplex from gram negative bacteria, method of purification and methods of use |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO2000018351A2 Aglyco products and methods of use |
| 04/06/2000 | WO2000018231A1 Methods for treating or preventing viral infections and associated diseases |